Voting Rights and Shares Capital of NANOBIOTIX

Nanobiotix, a biotechnology company listed on Euronext Paris and Nasdaq, announced its voting rights and share capital details as of September 30, 2026. The company has 50,967,610 shares outstanding. The total number of theoretical voting rights stands at 54,729,543, while exercisable voting rights total 54,707,425.

These figures comply with article L.233-8 II of the French Commercial Code and article 223-16 of the French Financial Markets Authority General Regulation. Nanobiotix, headquartered in Paris with a subsidiary in Cambridge, focuses on nanotechnology platforms in oncology, bioavailability, and central nervous system disorders.